You are viewing an incomplete version of our website. Please click to reload the website as full version.

NOTCH3 antibody (Notch 3) (N-Term)

Details for Product anti-NOTCH3 Antibody No. ABIN966685, Supplier: Login to see New
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Synonyms CADASIL, CASIL, IMF2, AW229011, N3, hpbk, fa14b08, notch5, wu:fa14b08
(66), (9), (5), (5), (4), (3), (2), (2), (2), (2), (1), (1)
(121), (46), (22), (3), (2), (1), (1), (1)
(60), (40), (23), (17), (2), (2), (2)
This NOTCH3 antibody is un-conjugated
(14), (10), (4), (4), (4), (4), (2), (2)
Immunohistochemistry (IHC)
(66), (64), (46), (33), (11), (10), (4), (3), (2), (1), (1), (1)
Pubmed 3 references available
Supplier Login to see New
Catalog number from supplier Login to see New
Quantity 0.1 mg
Shipping to United States ( )
Availability Will be delivered in 5 to 7 Business Days
Immunogen Polyclonal antibody produced in rabbits immunizing with a synthetic peptide corresponding to very N-terminal residues of human NOTCH3 (Neurogenic locus notch homolog protein 3)
Alternative Name NOTCH3 (NOTCH3 Antibody Abstract)
Background NOTCH3 (Neurogenic locus notch homolog protein 3) functions as a receptor for membrane-bound ligands Jagged1, Jagged2 and Delta1 to regulate cell-fate determination. Upon ligand activation through the released notch intracellular domain (NICD) it forms a transcriptional activator complex with RBP-J kappa and activates genes of the enhancer of split locus. NOTCH3 affects the implementation of differentiation, proliferation and apoptotic programs. NOTCH3 is a heterodimer of a C-terminal fragment N(TM) and a N-terminal fragment N(EC) which are probably linked by disulfide bonds. NOTCH3 interacts with MAML1, MAML2 and MAML3 which act as transcriptional coactivators for NOTCH3. NOTCH3 is ubiquitously expressed in fetal and adult tissues. It is synthesized in the endoplasmic reticulum as an inactive form which is proteolytically cleaved by a furin-like convertase in the trans-Golgi network before it reaches the plasma membrane to yield an active, ligand-accessible form. Cleavage results in a C-terminal fragment N(TM) and a N-terminal fragment N(EC). Following ligand binding, it is cleaved by TNF-alpha converting enzyme (TACE) to yield a membrane-associated intermediate fragment called notch extracellular truncation (NEXT). This fragment is then cleaved by presenilin dependent gamma-secretase to release a notch-derived peptide containing the intracellular domain (NICD) from the membrane. Defects in NOTCH3 are the cause of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). CADASIL causes a type of stroke and dementia of which key features include recurrent subcortical ischemic events and vascular dementia. The disorder affects relatively young adults of both sexes.
Pathways Notch Signaling
Restrictions For Research Use only
Product cited in: Wu, Sun, Kobayashi et al.: "Identification of a family of mastermind-like transcriptional coactivators for mammalian notch receptors." in: Molecular and cellular biology, Vol. 22, Issue 21, pp. 7688-700, 2002 (PubMed).

Gray, Mann, Mitsiadis et al.: "Human ligands of the Notch receptor." in: The American journal of pathology, Vol. 154, Issue 3, pp. 785-94, 1999 (PubMed).

Joutel, Corpechot, Ducros et al.: "Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia." in: Nature, Vol. 383, Issue 6602, pp. 707-10, 1996 (PubMed).

Catalog No. ABIN966685
Plus shipping costs $45.00

Order hotline:

  • +1 877 302 8632
  • +1 888 205 9894 (TF)